Alterola Biotech, Inc.
ABTI · OTC
3/31/2023 | 3/31/2022 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $46 | $2,432 | $0 | $0 |
| G&A Expenses | $1,651 | $4,039 | $330 | $258 |
| SG&A Expenses | $1,651 | $4,039 | $330 | $258 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,697 | $6,471 | $330 | $258 |
| Operating Income | -$1,897 | -$6,471 | -$330 | -$258 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $200 | $0 | $79 | -$0 |
| Pre-Tax Income | -$1,697 | -$6,471 | -$251 | -$259 |
| Tax Expense | -$155 | $0 | -$79 | $0 |
| Net Income | -$1,542 | -$6,471 | -$172 | -$259 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.008 | -0.002 | -0.002 |
| % Growth | 77.4% | -460% | 31.8% | – |
| EPS Diluted | -0.002 | -0.008 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 806,333 | 769,968 | 118,063 | 116,563 |
| Weighted Avg Shares Out Dil | 806,333 | 769,968 | 118,063 | 116,563 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $200 | $0 | $79 | $206 |
| EBITDA | -$1,697 | -$6,471 | -$251 | -$258 |
| % Margin | – | – | – | – |